Si è verificato un errore durante il caricamento della pagina.
Il nostro team è stato avvisato ma contattaci tramite il Widget assistenza email se il problema persiste.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | Yes |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Aquestive Therapeutics, Inc. |
| Luye Pharma Group Ltd. |
| Nektar Therapeutics |
| Shionogi & Co., Ltd. |
| Bristol-Myers Squibb Company |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| AQST | 2,186 | NKTR | 4,507 | BMY | EII | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 112% | 4% | -189% | 13% | 32% | 5% | ||
| Fiscal Year - 1 | 7% | 5% | -111% | 14% | 27% | 5% | ||
| Fiscal Year - 2 | 54% | 6% | -70% | 18% | 19% | 7% | ||
| Fiscal Year - 3 | 108% | -2% | -60% | 13% | 19% | 7% | ||
| Fiscal Year - 4 | 204% | 8% | -36% | 14% | -20% | 6% | ||
| Fiscal Year - 5 | -3347% | 17% | -28% | 17% | 10% | 19% | ||
| Average | -477% | 6% | -82% | 15% | 14% | 8% | ||
| Median | 81% | 6% | -65% | 14% | 19% | 6% | ||
| Benchmarks | Ticker | |||||||
| Aquestive Therapeutics, Inc. | NasdaqGM:AQST | |||||||
| Luye Pharma Group Ltd. | SEHK:2186 | |||||||
| Nektar Therapeutics | NasdaqCM:NKTR | |||||||
| Shionogi & Co., Ltd. | TSE:4507 | |||||||
| Bristol-Myers Squibb Company | NYSE:BMY | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | AQST | Dec-05 | NKTR | May-12 | BMY | EII | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Mar-25 | Dec-24 | Mar-25 | ||
| LTM Period | Mar-25 | Dec-24 | Mar-25 | Mar-25 | Mar-25 | Mar-25 | ||
| Revenues | ||||||||
| Latest Twelve Months | 54 | 6,061 | 87 | 438,268 | 47,636 | 789,400 | ||
| Fiscal Year | 58 | 6,061 | 98 | 438,268 | 48,300 | 789,400 | ||
| Fiscal Year - 1 | 51 | 6,143 | 90 | 435,081 | 45,006 | 741,751 | ||
| Fiscal Year - 2 | 48 | 5,982 | 92 | 426,684 | 46,159 | 744,402 | ||
| Fiscal Year - 3 | 51 | 5,200 | 102 | 335,138 | 46,385 | 756,226 | ||
| Fiscal Year - 4 | 46 | 5,540 | 153 | 297,177 | 42,518 | 645,942 | ||
| Fiscal Year - 5 | 53 | 6,358 | 115 | 333,371 | 26,145 | 695,621 | ||
| Net Income | ||||||||
| Latest Twelve Months | (54) | 472 | (133) | 170,435 | 5,419 | 46,432 | ||
| Fiscal Year | (44) | 472 | (119) | 170,435 | (8,948) | 46,432 | ||
| Fiscal Year - 1 | (8) | 533 | (276) | 162,030 | 8,025 | 42,406 | ||
| Fiscal Year - 2 | (54) | 605 | (368) | 184,965 | 6,327 | 55,432 | ||
| Fiscal Year - 3 | (71) | (134) | (524) | 114,185 | 6,994 | 47,954 | ||
| Fiscal Year - 4 | (56) | 707 | (444) | 111,858 | (9,015) | 42,119 | ||
| Fiscal Year - 5 | (66) | 1,396 | (441) | 122,193 | 3,439 | 121,767 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 130 | 25,491 | 396 | 1,416,918 | 99,031 | 1,393,799 | ||
| Latest Fiscal Quarter | 102 | 29,612 | 256 | 1,535,349 | 92,427 | 1,386,547 | ||
| Fiscal Year | 101 | 29,612 | 304 | 1,535,349 | 92,603 | 1,386,547 | ||
| Fiscal Year - 1 | 57 | 25,491 | 398 | 1,416,918 | 95,159 | 1,393,799 | ||
| Fiscal Year - 2 | 57 | 24,250 | 711 | 1,311,800 | 96,820 | 1,263,350 | ||
| Fiscal Year - 3 | 62 | 22,582 | 1,117 | 1,150,601 | 109,314 | 1,239,315 | ||
| Fiscal Year - 4 | 63 | 20,631 | 1,539 | 998,992 | 118,481 | 1,090,009 | ||
| Fiscal Year - 5 | 78 | 19,408 | 1,977 | 871,526 | 129,944 | 1,062,140 | ||
| Fiscal Year - 6 | 87 | 17,539 | 2,150 | 778,741 | 34,986 | 1,071,520 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | (36) | 12,531 | 127 | 1,235,325 | 16,490 | 875,614 | ||
| Latest Fiscal Quarter | (61) | 14,155 | 14 | 1,361,924 | 17,389 | 841,417 | ||
| Fiscal Year | (60) | 14,155 | 61 | 1,361,924 | 16,335 | 841,417 | ||
| Fiscal Year - 1 | (106) | 12,531 | 131 | 1,235,325 | 29,430 | 875,614 | ||
| Fiscal Year - 2 | (119) | 10,176 | 367 | 1,100,046 | 31,061 | 799,959 | ||
| Fiscal Year - 3 | (82) | 8,488 | 680 | 975,661 | 35,946 | 748,821 | ||
| Fiscal Year - 4 | (48) | 7,891 | 1,077 | 846,108 | 37,822 | 703,183 | ||
| Fiscal Year - 5 | (6) | 8,910 | 1,405 | 764,560 | 51,598 | 678,127 | ||
| Fiscal Year - 6 | 10 | 7,808 | 1,718 | 668,028 | 14,031 | 628,120 | ||